Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

v3.5.0.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2015
Mar. 21, 2016
Jun. 30, 2015
Document Information [Line Items]      
Document Type 10-K/A    
Amendment Flag true    
Entity Common Stock, Shares Outstanding   1,426,656  
Document Period End Date Dec. 31, 2015    
Document Fiscal Year Focus 2015    
Document Fiscal Period Focus FY    
Entity Registrant Name Global Medical REIT Inc.    
Entity Central Index Key 0001533615    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 0
Trading Symbol GMRE    
Amendment Description Global Medical REIT Inc. is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend our Annual Report on Form 10-K for the year ended December 31, 2015, originally filed with the Securities and Exchange Commission on March 21, 2016 (the “Original Filing”), to include the prior year consolidated financial information required by Rule 8-02 of Regulation S-X. This Amendment includes audited consolidated results of operations and cash flow information for the fiscal year ended August 31, 2014 within Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the fiscal year ended August 31, 2014 consolidated financial statements and footnotes within Item 8. “Consolidated Financial Statements and Supplementary Data.” On March 20, 2015, we filed a Transition Report on Form 10-KT for the year ended December 31, 2014, as the Company changed its fiscal year from August 31 to the calendar twelve months ending December 31, effective beginning with the year ended December 31, 2014. This change in fiscal year was required based upon our intention to qualify and be taxed as a real estate investment trust for federal income tax purposes. As a result, the Company’s 2014 fiscal period was shortened from twelve months to a four-month transition period that ended on December 31, 2014. Accordingly, our Original Filing included the Company’s audited consolidated financial results for the calendar year ended December 31, 2015 and for the four-month transition period from September 1, 2014 through December 31, 2014. This Amendment also includes updated Subsequent Event information in Note 11 - “Subsequent Events” that was included in our Original Filing from March 21, 2016 through March 31, 2016 to correspond with the date of the filing of our Registration Statement on Form S-11 on April 1, 2016. This Amendment does not amend or otherwise update any other information included in our Original Filing.